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A B S T R A C T
The aim of this study was to determine the efficacy and operative complications of the suprapubic arc (SPARC) proce-
dure in stress incontinent women with and without previous anti-incontinence surgery. One-hundred and twenty-one pa-
tients with stress urinary incontinence (SUI) were treated with SPARC for correction of urethral hypermobility (N=65)
and intrinsic sphincter deficiency (N=56) between August 2002 and February 2007. The long-term surgical results, oper-
ative complications (bladder injury, retropubic hematoma, de novo urgency and urinary infection) and patients’ satisfac-
tion were assessed. The overall complication rate was 9.9% (12/121). The perioperative complication rate was 1.7% in-
cluding 2 urinary bladder injuries. Significant difference in the overall complications rate was detected between women
with and without previous surgery (23/45, 51.1% vs. 6/108, 5.5%, c2=49.89, P<0.001). The overall postoperative compli-
cation rate was 8.3% (10/121) including 4 de novo urgencies, 4 urinary infections and 2 retropubic hematomas. There
were 3 patients with postoperative urinary retention managed conservatively, without voiding difficulties on control vis-
its. The objective cure rate after the follow-up was 86.8% (105/121). In patients with SUI and without preceding vaginal
operations SPARC is a good method with low incidence of perioperative complications, promising long-term results and
high patient satisfaction.
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Introduction
The suprapubic arc (SPARC) polypropylene midure-
thral sling is considered as one of the best surgical treat-
ment methods for women with stress urinary inconti-
nence. The reported success rate of the pubovaginal sling
procedures using various materials fluctuated impres-
sively from 80–95%1,2. Until recently, the procedure has
been reserved for patients who previously failed other
surgical treatments, but nowadays the indications are
extended and the treatment is widely applied in all types
of SUI2. Correction of suburethral support with adequate
intrinsic urethral resistance is important in achieving
continence especially in women with severe intrinsic
sphincter deficiency3,4. Since the needle passes at the
back surface of the symphysis, the risks for lower urinary
tract, bowel and vascular injury are outstandingly de-
creased5. In addition, this technique offers the surgeon
control of the path of the needle under finger guidance
and the exceptional tensioning design allows reducing or
increasing the tension after sling positioning. Relatively
high percentage of early postoperative complications,
well documented in the literature, are mostly associated
with the prior abdominal or vaginal surgery6. On the
other hand, certain dissapointing outcome was corre-
lated with the surgical technique designed to prevent
bladder outlet obstruction7,8. Some unsatisfactory surgi-
cal results of SPARC might derive from the high grade
type of SUI coupled with pelvic organ prolapse. Long-
-term outcome and complications of this surgical proce-
dure regarding the risk of persistent incontinence or
bladder outlet obstruction have not been well deter-
mined and explained.
The primary objectives of our retrospective cohort
study were to establish the safety, efficacy and postopera-
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tive complications of SPARC in women with previous
anti-incontinence surgical treatment and in women who
underwent SPARC-only operation.
Patients and Methods
A total of 121 women with SUI received SPARC proce-
dure for correction of urethral hypermobility and intrin-
sic urethral sphincter deficiency. A retrospective cohort
study was performed at our institution in the time period
between August 2002 and February 2007. All patients
were assessed preoperatively by quality of life questio-
nairre, physical examination and urodynamic study. Wo-
men were questioned preoperatively with regard to the
symptoms of stress and urge incontinence. Out of 121 pa-
tients, 65 women had signs of urethral hypermobility, 56
had been diagnosed as intrinsic sphincter deficiency. All
types of other vaginal support defects such as cystocoele,
rectocoele or uterine prolapse were eliminated from the
study. If the urgency was the predominant cause of the
incontinence participants were ruled out from the study.
All patients had sterile urine before the surgery.
Surgery
The SPARC procedure was performed under general
(N=87) or spinal anesthesia (N=34). The propylene sling
was positioned under the midurethra into the subcutane-
ous tunnel which passes at the posterior wall of the
symphisis through the endopelvic fascia without fixation
to the fascia and without tension until the cystoscopy and
provocation test have been completed. After the position-
ing of the tape the cystoscopy was done to check for the
bladder injury. The optimal tension was achieved by two
steps afterwards when the bladder was full: first the in-
strument was placed between the tape and midurethra
and then tensioned in order to avoid postoperative reten-
tion. Subsequently the continence was attested by deep
and intense compression of abdominal wall above the
symphisis. If the drops or slight leakage of urine were ob-
tained on the provocation test the tension was clarified
as ideal, with no risk for postoperative retention. A Foley
catheter was inserted in the bladder for 24 hours in aver-
age.
Outcome measures
The incidence of perioperative (bladder injury) and
early and late postoperative complications (retropubic
haemoatoma, voiding difficulties, infection, urinary re-
tention, de novo urgency), operating time, intraoperative
blood loss and hospitalization period were obtained. Re-
tention was defined if the residual urine was more than
50 mL after micturition. De novo urgency was identified
if the frequency, urgency, or urge incontinence developed
in patients who lacked urgency before operation and if it
persisted more than 30 days after the procedure. Urinary
infection was confirmed by the microbiological urine
analysis. All patients were followed-up at our Institution
6, 12 and 18 months postoperatively by questionnaire
and urogynecologic inspection.
Questionnaire
Objective cure rate was determined from the patients
symptoms, physical and urodynamic evaluation at each
postoperative visit. Satisfaction rate was assessed from
the straightforward questionnaire regarding the postop-
erative condition, improvement and potential postopera-
tive difficulties. The objective surgical results were clas-
sified as cured: without any lower urinary tract symptom,
no incontinence on provocation tests; improved: very
mild SUI on provocation test at first postoperative visit,
frequency, de novo urgency and strain to void; failed:
moderate to severe incontinence.
Statistical analysis
Statistical analysis was based on Pearson’s chi-square
test for categorical variables. Probabilities lower than 5%
(P<0.05) were considered significant. Statistics was done
with Statistical Package for Social Sciences, version 11
(SPSS Inc., Chicago, IL, USA) software.
Results
In 98 patients SPARC was the first operation, and the
remaining 23 had undergone the abdomino-pelvic opera-
tion previously (Table 1). There was no significant differ-
ence in the mean age, parity duration of symptoms and
hormonal state between the SPARC-only operation group
and group with previous surgery. Stress urinary inconti-
nence was identified as either urethral hypermobility
(N=65) or intrinsic sphincter deficiency (N=56). The
mean operating time was 20 ± 8 minutes (range 11–38
min). After the pubovaginal sling procedure all patients
could void volitionally with little residual urine (< 50
mL) on the first postoperative day after the removal of
the Foley catheter. The overall complication rate was
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TABLE 1
CHARACTERISTICS OF THE PATIENTS WITH SPARC
Patients’ characteristics
No (%) of patients
(N=121)
Age (mean ± S.D.) 51 ± 8.2
Hormonal age:
generative age
perimenopause
postmenopause
18 (14.9)
59 (48.8)
44 (36.3)
Parity ± S.D. 2.8 ± 1.4
Previous surgery:
abdominal hysterectomy
vaginal hysterectomy with colporraphy
correction of cystocoele
correction of urethral insufficiency
23 (19.0)
12 (9.9)
6 (5.0)
3 (2.5)
2 (1.7)
Stress urinary incontinence:
urethral hypermobility
intrinsic sphyncter deficiency
121 (100)
65 (53.7)
56 (46.3)
SPARC – Suprapubic arc
9.9% (12/121) (Table 2). Perioperative complications oc-
curred in 2 patients (1.7%) as bladder perforation (N=1)
or bladder laceration (N=1) and were both diagnozed
during routine cystoscopy. Lacerations were repaired with
sutures and perforations were simply drained until the
recovery. Bladder catheterization lasted a mean of 2.7 ±
1.9 days. The overall postoperative complication rate was
8.3% (10/121). Early postoperative complications were
urinary infection and retropubic hematoma.
De novo urinary tract infection occurred in 4 (3.3%)
patients and were immediately treated by appropriate
antibiotics. Retropubic hematoma occurred in 2 patients
and have been detected on the day after the surgery. In 3
patients urinary retention occurred after removal of ca-
theter so further 10–14 days of catheterisation was nec-
essary. No urinary retention or strain to void occurred on
routine check-up controls. The only late postoperative
complication, de novo urgency was observed in 4 patients
(3.3%). Normal vaginal healing has been noticed in all
patients. None of the patients required releasing of sling
tension and none of them had voiding difficulties or
strain to void. Significant difference in the overall com-
plications was detected between women with and with-
out previous abdominal or vaginal surgery (respectively,
9/23, 39.1% vs. 3/98, 3.1%, c2=39.99, P<0.001) (Table 2).
Bladder injury (perforation and laceration) occurred
in patients who had undergone prior surgery. One of
them have had prior vaginal hysterectomy and one ante-
rior colporraphy with the correction of sphyncter mecha-
nism. No bladder injury occured in SPARC-only opera-
tion group.
De novo urgency and urinary infection appeared more
frequently in patients who underwent SPARC as the sec-
ond operation than in women with SPARC-only opera-
tion (3/23, 13.0% vs. 1/98, 1.0%; c2=6.86, P<0.005) (Ta-
ble 2).
Hospitalization interval ranged from 2 to 10 days
(mean 3.1 ± 1.4).
We achieved the objective cure rate 86,8% (105/121)
and improvement was achieved in the remaining 6.7%
(8/121). The mean follow-up time was 38 ± 6.4 months.
The main postoperative symptom which persisted on the
check visits was de novo urgency in 4 cases and de novo
urinary infection in 4 patients. However, patients with de
novo urgency had higher satisfactory rate on the further
follow-up visits. There was no incident of recurrent SUI
and none of the patient failed SPARC procedure. Overall
satisfactory rate was 81.8% (99/121) including patients
with perioperative and postoperative difficulties. When
the SPARC was applied to women with pure stress uri-
nary incontinence and no preceding operation the objec-
tive cure rate was 87.6% (106/121).
Discussion
According to our results neither persistent urinary re-
tention nor severe SUI were detected after operation in
our study. Using the tight instrument, which was placed
between the tape and urethra prior to gradual tensioning
of the sling we performed routine cystocscopy by stress
provocation test. Bladder perforation or laceration in our
study occurred in women who previously underwent vag-
inal hysterectomy and correction of sphyncter mecha-
nism. Altered position of pelvic organs, adhesions, and
reduction of retropubic space might give explanation of
such feeble consequences. No bladder injury occurred in
the patients with SPARC-only operation. Vascular, bowel
or nerve injury reported previously, have also not been
detected. No infection, erosions or defective healing of
the vaginal wall were observed. Two sequels of asymp-
tomatic retropubic hematoma occurred in women with
history of abdominal hysterectomy with spontaneous re-
solution occurring two weeks postoperatively. It is valu-
able to detect that there were no alterations between the
preoperative and postoperative red blood cells count,
even in the patients with hematoma or bladder injury.
Even though some authors believe that the large size of
dilating connector attaching the tape to the SPARC nee-
dle is responsible for the increased blood loss9, we had no
such experience. Our most frequent postoperative com-
plications were urinary infection and de novo urgency.
Previous detrusor instability or chronic inflammation of
the bladder enhances the possibility of recurrent infec-
tion and need of continuous perioperative antibacterial
treatment. Very few cases (3/121) of urinary retention,
managed conservatively with no further voiding difficul-
ties, usually reported by prior investigations, were ob-
served in our study6,10.
Quite contradictory results of the SPARC procedures
have been reported by other researchers, mostly regard-
ing the cure rate and perioperative complications9–11.
High rate of mild to moderate SUI after operation, which
was associated with too slight tension of the tape and the
fear of outlet obstruction, was observed by some in-
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TABLE 2
COMPLICATIONS OF THE SPARC DEPENDING ON HISTORY OF PREVIOUS SURGERY
Group (N)
No (%) of patients with complication
overall
12 (9.9)
bladder injury
2 (1.7)
retropubic hematoma
2 (1.7)
de novo urinary
infection 4 (3.4)
de novo urgency
4 (3.4)
SPARC only (98) 3 (3.1)* 0 0 1 (1.0)‡ 1 (1.0)‡
Previous surgery (23) 9 (39.1)* 2 (8.7) 2 (8.7) 3 (13.0)‡ 3 (13.0)‡
SPARC – Suprapubic arc, SUI – Stress urinary incontinence; * P<0.001; ‡ P<0.005
vestigators4,8,12. High rate of perioperative complications,
particularly the bladder injury, might be somewhat ex-
plained by surgeon’s limited experience with the SPARC
method. Furthermore, current reports respected that the
risk of bladder injury was higher if there is a history of
prior anti-incontinence surgery6,13. We have to oppose
some previous researches14 and recapitulate that only
slight vaginal defects that originate from breaking or we-
akness of endopelvic fascia could be managed by SPARC,
while high grade protrusion of vaginal wall, cystocoella
or other genital descensus accompanied with SUI should
be coupled by other surgical techniques rather than com-
plementing the SPARC procedure. In addition, during
the past several years concept has been evolved toward a
spectrum of patients having explicitly intrinsic sphincter
deficiency or urethral hypermobility9,15. Uncomplicated
hematomas have been reported by previous multicenter
trails and, as in our trial, had reliable final outcome6,13.
Urinary infection and de novo urgency have been de-
scribed by other previous investigations6,10,16. This com-
plex problem has been described in the literature with a
frequency of 3 to 24%2. Postoperative detrusor overac-
tivity manifested as urgency, frequency and urge inconti-
nence, according to previous reports, might result from
suburethral nervous or myogenic irritation. Other au-
thors point out that the bladder instability originates not
only from the age and hormonal status but from the
changes in paraurethral collagen metabolism and sclero-
sis induced by polypropylene tape17,18. We consider that
the etiology of de novo urgency is multifactorial but
mainly derives from unrecognized detrusor instability
before the operation rather than from newly developed
bladder obstruction.
Comparing with the current studies on the SPARC ef-
ficiency we achieved promissing objective overall success
rate (86.8%). When we respected surgical results of pa-
tients with SUI and without preceding abdominal or vag-
inal operations objective success rate raised up more
(87.6%). Approved by our investigation SPARC has shown
up to be available, minimally invasive and rather safe
method for SUI. It especially refers to patients without
history of previous surgery and uncured urgency, offer-
ing a low incidence of perioperative complications and
exceptional objective results with high satisfactory rate.
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OPERATIVNE KOMPLIKACIJE I ISHOD METODE SPARC U LIJE^ENJU
STATI^KE INKONTINENCIJE MOKRA]E
S A @ E T A K
U radu je prikazana u~inkovitost metode SPARC i usporedba pojave komplikacija u bolesnica koje su prvi puta
operirane SPARCmetodom i bolesnica koje su ve} prethodno imale operacije dna zdjelice. Stotinu dvadeset i jedna `ena
sa stati~kom inkontinencijom operirana je SPARC metodom zbog hipermobilnosti uretre (n=65) odnosno intrinzi~nog
o{te}enja uretralnog sfinktera (n=56) u razdoblju izme|u kolovoza 2002 i velja~e 2007 godine. Prikazan je dugoro~ni
ishod, operativne komplikacije (ozljeda mjehura, retropubi~ni hematom, de novo urgencija, urinarna infekcija) te zado-
voljstvo bolesnica. Ukupan udio komplikacija bio je 9,9% (12/121). Perioperativnih komplikacija bilo je 1,7%, {to uklju-
~uje 2 ozljede mjehura. Zamije}ena je zna~ajna razlika u broju komplikacija izme|u bolesnica koje su prethodno operi-
rane odnosno onih kojima je ovo bila prva korekcija inkontinencije (9/23, 39,1% vs. 3/98, 3,1%, P<0,001). Ukupan broj
postoperativnih komplikacija bio je 8,3% (10/121) uklju~uju}i 4 de novo urgencije, 4 urinarne infekcije i 2 retropubi~na
hematoma. Nije bilo slu~ajeva trajne postoperativne urinarne retencije niti ote`anog mokrenja. Ukupna u~inkovitost
metode bila je 86,8% (105/121). U bolesnica s ~istom stati~kom inkontinencijom, a bez prethodne operativne korekcije,
SPARC je sigurna metoda, s niskim udjelom komplikacija i zadovoljavaju}im dugoro~nim ishodom.
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